Xiaopeng Mo

Crystal Structure Determination of New Antimitotic Agent Bis(p-fluorobenzyl)trisulfide

Xiurong Hu, Xiao Xu, Xiaobo Wang, 2008, AAPS PharmSciTech.

Antiglioma via regulating oxidative stress and remodeling tumor‐associated macrophage using lactoferrin‐mediated biomimetic codelivery of simvastatin/fenretinide

Yongzhuo Huang, Yang He, Tuanbing Liu, 2018, Journal of controlled release : official journal of the Controlled Release Society.

Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery

Qin Xu, Yongzhuo Huang, B. Wang, 2020, Journal for ImmunoTherapy of Cancer.

Quantitative determination of anti-tumor agent bis(4-fluorobenzyl)trisulfide, fluorapacin and its pharmaceutical preparation by high-performance liquid chromatography.

Xiao Xu, Xiaobo Wang, H. An, 2008, Journal of pharmaceutical and biomedical analysis.

Discovery of a Novel, Selective and Irreversible Inhibitor (Abivertinib) of Mutated EGFR and T790M-induced Resistance for the Treatment of NSCLC

Xiaoying Zhang, Xiao Xu, Lijun Xu, 2020, Medicine in Drug Discovery.

Stability studies of anticancer agent bis(4-fluorobenzyl)trisulfide and synthesis of related substances.

H. An, Xiaopeng Mo, Xiaoying Xu, 2008, Journal of pharmaceutical and biomedical analysis.

The intra-brain distribution of brain targeting delivery systems

Yongzhuo Huang, Ergang Liu, Xiaopeng Mo, 2019, Brain Targeted Drug Delivery System.

BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFRT790M mutation

Yakun Wan, Yongzhuo Huang, Pengfei Zhao, 2020, Theranostics.